These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19088045)

  • 1. Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response.
    Langer R; Ott K; Specht K; Becker K; Lordick F; Burian M; Herrmann K; Schrattenholz A; Cahill MA; Schwaiger M; Hofler H; Wester HJ
    Clin Cancer Res; 2008 Dec; 14(24):8279-87. PubMed ID: 19088045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients.
    Langer R; Ott K; Feith M; Lordick F; Specht K; Becker K; Hofler H
    J Surg Oncol; 2010 Oct; 102(5):503-8. PubMed ID: 20589706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray-based response prediction in esophageal adenocarcinoma.
    Schauer M; Janssen KP; Rimkus C; Raggi M; Feith M; Friess H; Theisen J
    Clin Cancer Res; 2010 Jan; 16(1):330-7. PubMed ID: 20028767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].
    Langer R; Specht K; Becker K; Ewald P; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
    Verh Dtsch Ges Pathol; 2004; 88():207-13. PubMed ID: 16892554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.
    Maher SG; Gillham CM; Duggan SP; Smyth PC; Miller N; Muldoon C; O'Byrne KJ; Sheils OM; Hollywood D; Reynolds JV
    Ann Surg; 2009 Nov; 250(5):729-37. PubMed ID: 19801928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas.
    Slotta-Huspenina J; Wolff C; Drecoll E; Feith M; Bettstetter M; Malinowsky K; Bauer L; Becker K; Ott K; Höfler H; Becker KF; Langer R
    Br J Cancer; 2013 Jul; 109(2):370-8. PubMed ID: 23839491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
    Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT
    Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study].
    Garajová I; Slabý O; Svoboda M; Fabian P; Silák J; Smerdová T; Kocák I; Růzicková J; Hoch J; Vyzula R
    Cas Lek Cesk; 2008; 147(7):381-6. PubMed ID: 18678097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.
    Luthra R; Wu TT; Luthra MG; Izzo J; Lopez-Alvarez E; Zhang L; Bailey J; Lee JH; Bresalier R; Rashid A; Swisher SG; Ajani JA
    J Clin Oncol; 2006 Jan; 24(2):259-67. PubMed ID: 16344314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.
    Slotta-Huspenina J; Berg D; Bauer K; Wolff C; Malinowsky K; Bauer L; Drecoll E; Bettstetter M; Feith M; Walch A; Höfler H; Becker KF; Langer R
    PLoS One; 2012; 7(7):e41420. PubMed ID: 22911792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic observations and P-glycoprotein expression in gastric and esophageal adenocarcinomas treated with preoperative chemotherapy.
    Robey-Cafferty SS; Ajani JA; Ota DM; Roth JA; Bruner JM
    Arch Pathol Lab Med; 1991 Aug; 115(8):807-12. PubMed ID: 1713759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
    Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer.
    Grimminger P; Vallböhmer D; Hoffmann A; Schulte C; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R; Brabender J
    J Surg Oncol; 2009 Nov; 100(6):447-51. PubMed ID: 19653263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation.
    Maher SG; McDowell DT; Collins BC; Muldoon C; Gallagher WM; Reynolds JV
    Ann Surg; 2011 Nov; 254(5):809-16; discussion 816-7. PubMed ID: 22005152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP60 may predict good pathological response to neoadjuvant chemoradiotherapy in bladder cancer.
    Urushibara M; Kageyama Y; Akashi T; Otsuka Y; Takizawa T; Koike M; Kihara K
    Jpn J Clin Oncol; 2007 Jan; 37(1):56-61. PubMed ID: 17095522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pretherapeutic and posttherapeutic expression levels of chemotherapy-associated genes in adenocarcinomas of the esophagus treated by 5-fluorouracil- and cisplatin-based neoadjuvant chemotherapy.
    Langer R; Specht K; Becker K; Ewald P; Ott K; Lordick F; Siewert JR; Höfler H
    Am J Clin Pathol; 2007 Aug; 128(2):191-7. PubMed ID: 17638652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
    Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
    Lee E; Nichols P; Spicer D; Groshen S; Yu MC; Lee AS
    Cancer Res; 2006 Aug; 66(16):7849-53. PubMed ID: 16912156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.